218 related articles for article (PubMed ID: 34049473)
1. Ginsenoside Rh1 Improves Type 2 Diabetic Nephropathy through AMPK/PI3K/Akt-Mediated Inflammation and Apoptosis Signaling Pathway.
Su WY; Li Y; Chen X; Li X; Wei H; Liu Z; Shen Q; Chen C; Wang YP; Li W
Am J Chin Med; 2021; 49(5):1215-1233. PubMed ID: 34049473
[TBL] [Abstract][Full Text] [Related]
2. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative Effects of Malonyl Ginsenoside from
Wang DS; Wang JM; Zhang FR; Lei FJ; Wen X; Song J; Sun GZ; Liu Z
Am J Chin Med; 2022; 50(3):863-882. PubMed ID: 35282802
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt/FOXO1 pathway.
Su WY; Fan ML; Li Y; Hu JN; Cai EB; Zhu HY; Song MJ; Li W
Chin J Nat Med; 2022 Sep; 20(9):669-678. PubMed ID: 36162952
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
Liu Y; Deng J; Fan D
Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
[TBL] [Abstract][Full Text] [Related]
6. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
8. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
9. Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues.
Wang P; Liu Y; Kang SY; Lyu C; Han X; Ho T; Lee KJ; Meng X; Park YK; Jung HW
Chin J Integr Med; 2024 Feb; 30(2):125-134. PubMed ID: 37118530
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Zhu Y; Zhu C; Yang H; Deng J; Fan D
Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
[TBL] [Abstract][Full Text] [Related]
11. Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.
Nie Y; Fu C; Zhang H; Zhang M; Xie H; Tong X; Li Y; Hou Z; Fan X; Yan M
BMC Complement Med Ther; 2020 Oct; 20(1):321. PubMed ID: 33097050
[TBL] [Abstract][Full Text] [Related]
12. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
[TBL] [Abstract][Full Text] [Related]
13. Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice.
Wang T; Wen X; Zhang Z; Xie M; Zhou J
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S487-S496. PubMed ID: 34649470
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
15. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
Song Y; Liu W; Tang K; Zang J; Li D; Gao H
J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
[TBL] [Abstract][Full Text] [Related]
16. Study on the inhibitive effect of Catalpol on diabetic nephropathy.
Chen J; Yang Y; Lv Z; Shu A; Du Q; Wang W; Chen Y; Xu H
Life Sci; 2020 Sep; 257():118120. PubMed ID: 32693244
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin's renoprotective effect in a diabetic nephropathy model in rats: The potential role of PI3K/AKT pathway.
Mohamed RH; Sedky AA; Hamam GG; Elkhateb L; Kamar SA; Adel S; Tawfik SS
Fundam Clin Pharmacol; 2022 Apr; 36(2):324-337. PubMed ID: 34735026
[TBL] [Abstract][Full Text] [Related]
18. Rare Ginsenoside 20(R)-Rg3 Inhibits D-Galactose-Induced Liver and Kidney Injury by Regulating Oxidative Stress-Induced Apoptosis.
Li W; Wang JQ; Zhou YD; Hou JG; Liu Y; Wang YP; Gong XJ; Lin XH; Jiang S; Wang Z
Am J Chin Med; 2020; 48(5):1141-1157. PubMed ID: 32668974
[TBL] [Abstract][Full Text] [Related]
19. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
20. Harmine alleviated STZ-induced rat diabetic nephropathy: A potential role via regulating AMPK/Nrf2 pathway and deactivating ataxia-telangiectasia mutated (ATM) signaling.
Tabaa MME; Tabaa MME; Rashad E; Elballal MS; Elazazy O
Int Immunopharmacol; 2024 May; 132():111954. PubMed ID: 38554444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
